Can Targeting Metabolism Be a Therapeutic Strategy?
Given the distinct metabolic features of cancer cells, targeting these pathways offers a promising therapeutic strategy. Inhibitors of glycolysis, such as 2-deoxyglucose, and glutaminase inhibitors are currently being explored in clinical trials. Additionally, drugs that target specific enzymes in lipid metabolism are being investigated for their potential to disrupt cancer cell growth.
